Sanofi (SNY) Debt to Equity (2016 - 2024)
Historic Debt to Equity for Sanofi (SNY) over the last 17 years, with Q2 2025 value amounting to $0.29.
- Sanofi's Debt to Equity fell 200.94% to $0.29 in Q2 2025 from the same period last year, while for Jun 2025 it was $0.29, marking a year-over-year decrease of 200.94%. This contributed to the annual value of $0.21 for FY2024, which is 717.67% down from last year.
- Per Sanofi's latest filing, its Debt to Equity stood at $0.29 for Q2 2025, which was down 200.94% from $0.21 recorded in Q4 2024.
- Sanofi's 5-year Debt to Equity high stood at $7.99 for Q2 2021, and its period low was $0.21 during Q4 2024.
- Moreover, its 5-year median value for Debt to Equity was $0.27 (2022), whereas its average is $1.12.
- Its Debt to Equity has fluctuated over the past 5 years, first surged by 203831.05% in 2021, then plummeted by 9666.57% in 2022.
- Quarter analysis of 5 years shows Sanofi's Debt to Equity stood at $0.3 in 2021, then fell by 13.93% to $0.25 in 2022, then fell by 13.0% to $0.22 in 2023, then dropped by 7.18% to $0.21 in 2024, then surged by 42.0% to $0.29 in 2025.
- Its Debt to Equity was $0.29 in Q2 2025, compared to $0.21 in Q4 2024 and $0.3 in Q2 2024.